Anyfanti, P.; Evangelidis, P.; Tragiannidis, K.; Antza, C.; Poulis, D.; Dimitroulas, T.; Kotsis, V.
Targeting Inflammatory Pathways in Chronic Low Back Pain: Opportunities for Novel Therapeutics. Pharmaceuticals 2025, 18, 1612.
https://doi.org/10.3390/ph18111612
AMA Style
Anyfanti P, Evangelidis P, Tragiannidis K, Antza C, Poulis D, Dimitroulas T, Kotsis V.
Targeting Inflammatory Pathways in Chronic Low Back Pain: Opportunities for Novel Therapeutics. Pharmaceuticals. 2025; 18(11):1612.
https://doi.org/10.3390/ph18111612
Chicago/Turabian Style
Anyfanti, Panagiota, Paschalis Evangelidis, Konstantinos Tragiannidis, Christina Antza, Dimitrios Poulis, Theodoros Dimitroulas, and Vasilios Kotsis.
2025. "Targeting Inflammatory Pathways in Chronic Low Back Pain: Opportunities for Novel Therapeutics" Pharmaceuticals 18, no. 11: 1612.
https://doi.org/10.3390/ph18111612
APA Style
Anyfanti, P., Evangelidis, P., Tragiannidis, K., Antza, C., Poulis, D., Dimitroulas, T., & Kotsis, V.
(2025). Targeting Inflammatory Pathways in Chronic Low Back Pain: Opportunities for Novel Therapeutics. Pharmaceuticals, 18(11), 1612.
https://doi.org/10.3390/ph18111612
